BACE1 and Alzheimer disease: More recently, a generative AI framework applied to BACE1 produced novel scaffolds with in silico-predicted potency against Alzheimer’s disease, representing the first AI-only de novo discovery of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors [113].